World Journal of Hematology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 664699

Number of visits today: 45

Number of downloads: 564388

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (825)

Contents Volume 6 Issue 3 August 6, 2017

Review

Aspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibition

Jan Jacques Michiels

World J Hematol 6(3):32-54. Published online Aug 6, 2017. doi: 10.5315/wjh.v6.i3.32

Abstract (2411) | Core Tip (2046) | Full Article (HTML) (19303) | Figures (1-19) (963) | Tables (1-4) (904) | Full Article (PDF)-3604K (975) | Audio-2626K (79) | Peer-Review Report-93K (529) | Answering Reviewers-217K (495) | Received: 03/20/2017 | Revised: 04/27/2017 | Accepted: 07/17/2017 | RCA | CrossRef | Google Scholar | Times Cited (5) | Total Visits (38226) | Similar Articles (32) | Timeline of Article Publication (15) | Cite |

(3) | (0) | (0) | (0) | Open

Minireviews

Oxidative alterations in sickle cell disease: Possible involvement in disease pathogenesis

Yesim Oztas, Ahmet Yalcinkaya

World J Hematol 6(3):55-61. Published online Aug 6, 2017. doi: 10.5315/wjh.v6.i3.55

Abstract (1792) | Core Tip (1492) | Full Article (HTML) (7037) | Figures (1-1) (438) | Full Article (PDF)-1271K (975) | Audio-591K (226) | Peer-Review Report-115K (439) | Answering Reviewers-153K (416) | Received: 01/08/2017 | Revised: 04/25/2017 | Accepted: 05/22/2017 | RCA | CrossRef | Google Scholar | Times Cited (10) | Total Visits (23120) | Similar Articles (8) | Timeline of Article Publication (18) | Authors Evaluation (1) | Cite |

(0) | (0) | (0) | (0) | Open

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.